PERSONALIZE MY TREATMENT (PMT)
DEAD

Serial Number

90226501

Owner

Exactis Innovation

Attorney

John Zaccaria

Filing Date

Sep 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PERSONALIZE MY TREATMENT (PMT) Trademark

Serial Number: 90226501

PERSONALIZE MY TREATMENT (PMT) is a trademark filed by Exactis Innovation on September 30, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Exactis Innovation (3 trademarks)

522-5450 Ch De La Côte-Des-Neiges
Montréal, Québec H3T1Y6 , CA

Entity Type: 03

Trademark Details

Filing Date

September 30, 2020

Registration Date

Not Registered

Goods & Services

Biobank services in the nature of providing access to a bank of human blood, biological and tissue samples for cancer patients

Platform as a service (PAAS) featuring computer software platforms in the field of oncology, for matching cancer patients to biology driven clinical trials based on the molecular profile of their tumour; providing an on-line computer database in the field of medical and scientific research information in the field of clinical trials, featuring medical and scientific research information pertaining to a patient's molecular, clinical, epidemiological data and research findings for use in silico trial design, for matching cancer patients to clinical trials and for studying health econometrics; providing an on-line computer database in the field of medical and scientific research as it pertains to cancer treatment, diagnosis and molecular profiling

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 3, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 3, 2025 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 7, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 7, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 7, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 7, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 7, 2024 GNSL
SUSPENSION LETTER WRITTEN
Mar 7, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 19, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 7, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 7, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 7, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 21, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 21, 2023 GNSL
SUSPENSION LETTER WRITTEN
Apr 21, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2023 CRFA
ASSIGNED TO LIE
Apr 20, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 12, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 27, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 27, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 27, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 15, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 15, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jul 15, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2022 CRFA
ASSIGNED TO LIE
May 28, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 25, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 28, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 28, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 28, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 27, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 19, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 19, 2021 GNSL
SUSPENSION LETTER WRITTEN
Apr 19, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 25, 2021 GNRN
NON-FINAL ACTION E-MAILED
Feb 25, 2021 GNRT
NON-FINAL ACTION WRITTEN
Feb 25, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2020 NWOS
NEW APPLICATION ENTERED
Oct 3, 2020 NWAP